back to Meetings page
- IMMPACT-XX Slide Presentations
- 1. Interstitial cystitis: overview and assessment of pain outcomes and Implications for Inclusion criteria
- Henry Lai, MD
- 2. Prostatitis: overview and assessment of pain outcomes and implications for inclusion criteria
- Michel Pontari, MD
- 3. Vulvodynia: overview and assessment of pain outcomes and implications for inclusion criteria
- Andrea Rapkin, MD
- 4. IBS: overview and assessment of pain outcomes and implications for inclusion criteria
- William Chey, MD
- 5. FDA approach to clinical outcome assessments
- Sarrit Kovacs, PhD
- 6. FDA approach to clinical endpoint development
- Laura Lee Johnson, PhD
- 7. Clinical trials of interstitial cystitis: regulatory perspective
- Roger Wiederhorn, MD
- 8. Clinical trials of prostatitis: regulatory perspective
- Jordan Dimitrakoff, MD, PhD
- 9. Clinical trials of IBS: regulatory perspective
- Lesley Hanes, MD, MSc
- 10. Systematic review of chronic pelvic pain and IBS clinical trials: pain outcome measures and inclusion criteria
- Jennifer Gewandter, PhD, MPH
- 11. Lessons learned from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) study
- Quentin Clemens, MD
- 12. Lessons learned along the path to qualification of an IBS outcome measure
- Stephen Joel Coons, PhD